CytoMed Therapeutics Limited(GDTC)
$0.83-0.02 (-1.78%)
GDTC
CytoMed Therapeutics Limited financials statements
$0.83
At close:-0.02 (-1.78%)
Want to see GDTC full AI Analyst Report?
CytoMed Therapeutics Limited (GDTC) Income Statement
23 Followers
CytoMed Therapeutics Limited Income Statement
Last quarter (Q2 2026), CytoMed Therapeutics Limited's total revenue was S$157.29K, an increase of 0.90% from the same quarter last year. In Q2, CytoMed Therapeutics Limited's net income was S$-1.77M. See CytoMed Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| S$ 324.39K | S$ 69.50K | S$ 0.00 | S$ 0.00 | S$ 0.00 | |
| S$ 256.39K | S$ 52.38K | S$ -4.36M | S$ 0.00 | S$ 110.29K | |
| S$ 5.05M | S$ 3.65M | S$ 0.00 | S$ 2.34M | S$ 1.27M | |
| Depreciation and Amortization | S$ 401.58K | S$ 335.36K | S$ 381.15K | S$ 392.87K | S$ 329.88K |
| S$ -3.57M | S$ -2.17M | S$ -3.70M | S$ -2.61M | S$ -1.56M | |
| S$ -4.79M | S$ -3.60M | S$ -4.36M | S$ -2.34M | S$ -1.16M | |
| S$ 792.74K | S$ 1.08M | S$ 228.51K | S$ -789.97K | S$ -900.44K | |
| S$ -4.00M | S$ -2.52M | S$ -4.13M | S$ -3.13M | S$ -2.06M | |
| S$ -3.98M | S$ -2.52M | S$ -4.13M | S$ -3.13M | S$ -2.07M | |
| Per Share Metrics | |||||
| Basic EPS | S$ -0.34 | S$ -0.22 | S$ -0.39 | S$ -0.40 | S$ -0.30 |
| Diluted EPS | S$ -0.34 | S$ -0.22 | S$ -0.39 | S$ -0.40 | S$ -0.30 |
| Weighted Average Shares Outstanding | 11.65M | 11.54M | 10.63M | 7.92M | 6.93M |
| Weighted Average Shares Outstanding (Diluted) | 11.65M | 11.54M | 10.63M | 7.92M | 6.93M |
Currency in SGD

